Standout Papers

Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pra... 2003 2026 2010 2018 1.1k
  1. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR**STELLAR = Statin Therapies for Elevated Lipid Levels compared Across doses to Rosuvastatin. Trial) (2003)
    Peter H. Jones, Michael H. Davidson et al. The American Journal of Cardiology
  2. Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management (2010)
    Steven R. Smith, Neil J. Weissman et al. New England Journal of Medicine
  3. National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report (2015)
    Terry A. Jacobson, Matthew K. Ito et al. Journal of clinical lipidology
  4. Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol (2019)
    Kausik K. Ray, Harold Bays et al. New England Journal of Medicine
  5. National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 – executive summary (2014)
    Terry A. Jacobson, Matthew K. Ito et al. Journal of clinical lipidology
  6. Anti-PCSK9 Monotherapy for Hypercholesterolemia (2014)
    Michael J. Koren, Michael A. Bolognese et al. Journal of the American College of Cardiology
  7. Reduction in Lipoprotein(a) With PCSK9 Monoclonal Antibody Evolocumab (AMG 145) (2014)
    Frederick J. Raal, Robert P. Giugliano et al. Journal of the American College of Cardiology
  8. Obesity and cardiovascular disease: mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity Federation (2022)
    Francisco López-Jiménez, Wael Almahmeed et al. European Journal of Preventive Cardiology
  9. Ten things to know about ten cardiovascular disease risk factors (2021)
    Harold Bays, Pam R. Taub et al. SHILAP Revista de lepidopterología
  10. Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis (2024)
    Henning Bliddal, Harold Bays et al. New England Journal of Medicine

Immediate Impact

2 by Nobel laureates 2 from Science/Nature 135 standout
Sub-graph 1 of 13

Citing Papers

Obesity in adults
2024 Standout
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk
2024 Standout
48 intermediate papers

Works of Harold Bays being referenced

National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report
2015 Standout
Safety Considerations with Niacin Therapy
2006
and 18 more

Author Peers

Author Last Decade Papers Cites
Harold Bays 9692 6931 2282 3290 342 18.1k
Michael H. Davidson 12546 8149 975 4396 414 22.4k
Paul N. Durrington 7434 6434 2322 3225 282 19.3k
James M. McKenney 10019 7409 1022 4894 154 20.7k
Donald B. Hunninghake 11083 9241 1090 7363 167 25.9k
Moses Elisaf 7397 6776 1554 3572 679 20.6k
D. Roger Illingworth 6854 6205 790 4042 162 17.8k
Peter P. Tóth 8048 5238 589 3755 512 15.9k
Helen M. Colhoun 7813 8596 1131 4058 273 18.6k
Jean Davignon 9842 5411 854 3704 267 19.2k
Chris J. Packard 7876 7235 510 4657 204 18.5k

All Works

Loading papers...

Rankless by CCL
2026